• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺髓样癌的遗传和临床特征:哥斯达黎加一个单一中心的经验。

Genetic and Clinical Features of Medullary Thyroid Carcinoma: The Experience of a Single Center in Costa Rica.

作者信息

Calvo Javier, Torrealba Gabriel, Sáenz Adriana, Santamaría Carlos, Morera Estela, Alvarado Silvia, Roa Yolanda, González Michelle

机构信息

Division of Endocrinology, Department of Internal Medicine, Hospital Rafael Ángel Calderón Guardia, San José, Costa Rica.

Neuromodulation Center, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

J Cancer Epidemiol. 2016;2016:9637173. doi: 10.1155/2016/9637173. Epub 2016 Nov 27.

DOI:10.1155/2016/9637173
PMID:28018431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5149694/
Abstract

. Activating mutations in the gene leads to medullary thyroid carcinoma (MTC). Guidelines encourage performing analysis in subjects with hereditary and sporadic disease. . . Observational, case series report study. . Subjects diagnosed with MTC, with a thyroidectomy performed in a single center in Costa Rica between the years 2006 and 2015. . Pre- and postoperative calcitonin, mutation, and neck ultrasound and tomography were obtained. . 21 subjects with histological diagnosis of MTC were followed up. The average age at diagnosis was 52.0 ± 15.7 years. The preoperative mean value of calcitonin was 1340 ± 665 pg/mL. Evidence of mutation was found in 26.3% of the patients, with only 2 of them grouped in the same kindred. We found statistically significant differences in mean ages between mutated (38.4 ± 20.2 y) versus nonmutated (54.6 ± 11.8 y, = 0.04). There were no significant differences regarding tumor size, metastases, and surgical reintervention. . We report the results of mutation analysis in subjects with MTC in a single center of Costa Rica. The availability of this tool increases the probability of identifying familial MTC, with the benefit of detecting affected subjects and their relatives at an earlier age.

摘要

该基因的激活突变会导致甲状腺髓样癌(MTC)。指南鼓励对遗传性和散发性疾病患者进行该分析。……观察性病例系列报告研究。……2006年至2015年间在哥斯达黎加的一个单一中心接受甲状腺切除术且被诊断为MTC的患者。……获取术前和术后的降钙素、该基因突变情况以及颈部超声和断层扫描结果。……对21例经组织学诊断为MTC的患者进行随访。诊断时的平均年龄为52.0±15.7岁。术前降钙素的平均值为1340±665 pg/mL。26.3%的患者发现有该基因突变证据,其中只有2例属于同一家族。我们发现突变组(38.4±20.2岁)与未突变组(54.6±11.8岁,P = 0.04)的平均年龄存在统计学显著差异。在肿瘤大小、转移情况和手术再次干预方面没有显著差异。……我们报告了在哥斯达黎加一个单一中心对MTC患者进行该基因突变分析的结果。该工具的可用性增加了识别家族性MTC的可能性,有利于在更早年龄发现受影响的患者及其亲属。

相似文献

1
Genetic and Clinical Features of Medullary Thyroid Carcinoma: The Experience of a Single Center in Costa Rica.甲状腺髓样癌的遗传和临床特征:哥斯达黎加一个单一中心的经验。
J Cancer Epidemiol. 2016;2016:9637173. doi: 10.1155/2016/9637173. Epub 2016 Nov 27.
2
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.遗传性和散发性甲状腺髓样癌的基因诊断的临床实用性。
Ann Endocrinol (Paris). 2019 Jun;80(3):187-190. doi: 10.1016/j.ando.2019.04.014. Epub 2019 Apr 11.
3
Diagnosis and management of medullary thyroid carcinoma.甲状腺髓样癌的诊断与管理
Clin Lab Med. 2004 Mar;24(1):49-83. doi: 10.1016/j.cll.2004.01.006.
4
RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.甲状腺髓样癌患者及其亲属的RET基因筛查:一个中心807例个体的经验
J Clin Endocrinol Metab. 2007 Dec;92(12):4725-9. doi: 10.1210/jc.2007-1005. Epub 2007 Sep 25.
5
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.挪威2A型多发性内分泌腺瘤病的全国性研究:甲状腺髓样癌临床病程的预测和预后因素
Thyroid. 2016 Sep;26(9):1225-38. doi: 10.1089/thy.2015.0673. Epub 2016 Aug 11.
6
[Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].[中国家系中由RET原癌基因p.C618Y突变引起的家族性甲状腺髓样癌的临床诊断与治疗]
Zhonghua Yi Xue Za Zhi. 2013 Feb 5;93(6):440-4.
7
Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.散发型甲状腺髓样癌患者中,通过种系RET癌基因突变分析支持的单侧手术。
World J Surg. 2000 Nov;24(11):1367-72. doi: 10.1007/s002680010226.
8
Medullary Thyroid Carcinoma Associated with Germline RET Mutation.与种系RET突变相关的甲状腺髓样癌
Thyroid. 2016 Dec;26(12):1744-1751. doi: 10.1089/thy.2016.0374. Epub 2016 Oct 18.
9
[Prophylactic thyroidectomy in children and young people with hereditary medullary thyroid carcinoma: a Chilean experience].[遗传性甲状腺髓样癌儿童及青少年的预防性甲状腺切除术:智利的经验]
Rev Med Chil. 2005 Sep;133(9):1029-36. doi: 10.4067/s0034-98872005000900005. Epub 2005 Nov 9.
10
M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds.M918V RET基因突变导致家族性甲状腺髓样癌:对8个患病家族的研究
Endocr Relat Cancer. 2016 Dec;23(12):909-920. doi: 10.1530/ERC-16-0141.

引用本文的文献

1
Epidemiology of Thyroid Carcinomas in North Macedonia (1999-2015).北马其顿甲状腺癌的流行病学(1999-2015 年)。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211004286. doi: 10.1177/21501327211004286.
2
Outcome of Treatment for Medullary Thyroid Carcinoma-a Single Centre Experience.甲状腺髓样癌的治疗结果——单中心经验
Indian J Surg Oncol. 2018 Mar;9(1):52-58. doi: 10.1007/s13193-017-0718-2. Epub 2017 Dec 8.
3
When should genetic testing be performed in patients with neuroendocrine tumours?何时应对神经内分泌肿瘤患者进行基因检测?
Rev Endocr Metab Disord. 2017 Dec;18(4):499-515. doi: 10.1007/s11154-017-9430-3.

本文引用的文献

1
New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double mutations.晚期甲状腺髓样癌分子特征的新见解:双突变病例预后不良的证据。
J Med Genet. 2016 Nov;53(11):729-734. doi: 10.1136/jmedgenet-2016-103833. Epub 2016 Jul 28.
2
Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.日本散发性甲状腺髓样癌患者中生殖系RET突变携带者:单中心经验
Auris Nasus Larynx. 2016 Oct;43(5):551-5. doi: 10.1016/j.anl.2015.12.016. Epub 2016 Feb 1.
3
Management of advanced medullary thyroid cancer.晚期甲状腺髓样癌的治疗管理。
Lancet Diabetes Endocrinol. 2016 Jan;4(1):64-71. doi: 10.1016/S2213-8587(15)00337-X. Epub 2015 Oct 23.
4
Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.使用细针穿刺降钙素检测甲状腺髓样癌:一项系统评价。
Diagn Cytopathol. 2016 Jan;44(1):45-51. doi: 10.1002/dc.23375. Epub 2015 Oct 19.
5
The development of rapid and accurate screening test for RET hotspot somatic and germline mutations in MEN2 syndromes.用于MEN2综合征中RET热点体细胞和生殖系突变的快速准确筛查试验的开发。
Exp Mol Pathol. 2015 Dec;99(3):416-25. doi: 10.1016/j.yexmp.2015.08.017. Epub 2015 Aug 29.
6
Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.中国甲状腺髓样癌患者及其亲属中RET基因突变的筛查
Fam Cancer. 2016 Jan;15(1):99-104. doi: 10.1007/s10689-015-9828-6.
7
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
8
Genetic screening of patients with medullary thyroid cancer in a referral center in Greece during the past two decades.在过去的二十年中,对希腊一家转诊中心的甲状腺髓样癌患者进行了基因筛查。
Eur J Endocrinol. 2015 Apr;172(4):501-9. doi: 10.1530/EJE-14-0817. Epub 2015 Jan 26.
9
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?二十年的经验教训:RET基因筛查检测如何影响甲状腺髓样癌的临床管理?
Clin Endocrinol (Oxf). 2015 Jun;82(6):892-9. doi: 10.1111/cen.12686. Epub 2014 Dec 29.
10
Update on medullary thyroid cancer.甲状腺髓样癌的最新进展。
Endocrinol Metab Clin North Am. 2014 Jun;43(2):423-42. doi: 10.1016/j.ecl.2014.02.004.